eteplirsen (Exondys 51) Report issue

Biologics Nucleic acid Orphan Drug FDA Approved FDA Fast Track FDA Accelerated Approval FDA Priority Review FDA
Back

Drug Pricing Summary

VA Big4

$1222.1100 - $6110.5500

VA FSS

$1591.9600 - $7959.8000

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
eteplirsen 50 mg / 1 mL (1 mL INJECTION) $1222.1100 VA Big4
  • Exondys 51 (1)
  • Sarepta Therapeutics Inc.
    eteplirsen 50 mg / 1 mL (1 mL INJECTION) $1591.9600 VA FSS
  • Exondys 51 (1)
  • Sarepta Therapeutics Inc.
    eteplirsen 50 mg / 1 mL (1 mL INJECTION) $6110.5500 VA Big4
  • Exondys 51 (1)
  • Sarepta Therapeutics Inc.
    eteplirsen 50 mg / 1 mL (1 mL INJECTION) $7959.8000 VA FSS
  • Exondys 51 (1)
  • Sarepta Therapeutics Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue